Clinical Trial Update: rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on rhDNase eye drops for ocular graft-versus-host disease and dry eye, terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Ocular Graft-versus-host Disease

Drugs mentioned

• rhDNase eye drops (recombinant human DNase I)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Ocular Graft vs Host Disease, Dry Eye | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-08-10